Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck-Reference-Cited by-同舟云学术

Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck

Published:2018-09-18 Issue:5 Volume:111 Page:490-497
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Bauml Joshua M¹²,Vinnakota Ravi³,Anna Park Yeun-Hee³⁴,Bates Susan E³⁴,Fojo Tito³⁴,Aggarwal Charu²,Limaye Sewanti³,Damjanov Nevena¹²,Di Stefano Jessica¹,Ciunci Christine²,Genden Eric M⁵,Wisnivesky Juan P⁶,Ferrandino Rocco⁶,Mamtani Ronac²,Langer Corey J²,Cohen Roger B²,Sigel Keith³⁶⁷

Affiliation:

1. Department of Medicine, Division of Hematology/Oncology, Michael J. Crescenz VA Medical Center, Philadelphia, PA

2. Department of Medicine, Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

3. Department of Medicine, Division of Hematology/Oncology, James J. Peters VA Medical Center, Bronx, NY

4. Department of Medicine, Division of Hematology/Oncology, The College of Physicians and Surgeons at Columbia University, New York, NY

5. Department of Otolaryngology, The Mount Sinai School of Medicine, New York, NY

6. Department of Medicine, Division of General Internal Medicine, The Mount Sinai School of Medicine, New York, NY

7. Department of Medicine, Division of Infectious Disease, The Mount Sinai School of Medicine, New York, NY

Funder

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/111/5/490/28580411/djy133.pdf

Reference47 articles.

1. Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer;Adelstein;Cancer,1990

2. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

3. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer;Forastiere;J Clin Oncol,2013

4. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck;Cooper;N Engl J Med,2004

5. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer;Bernier;N Engl J Med,2004

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment;Ear & Hearing;2024-09-12

2. Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer;European Archives of Oto-Rhino-Laryngology;2024-09-06

3. The role of prehabilitation in HNSCC patients treated with chemoradiotherapy;Supportive Care in Cancer;2024-09-05

4. The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin‐based chemoradiotherapy in patients with head and neck squamous cell carcinoma;Head & Neck;2024-08-02

5. The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy;Cancer Medicine;2024-08